Structural-First Formulations for Modern Clinics
A boutique selection of supplements designed to support your unique health story, from day one to forever.
Why We Do Things
Differently
Many peptide products rely on aggressive absorption strategies designed to force permeability. Our philosophy is different. We focus on structural design and formulation integrity rather than chemical permeation enhancers.
- NO aggressive absorption systems
- NO solubility manipulation
- NO surfactant-based permeation enhancers
- NO SNAC (Salcaprozate Sodium)
- NO arginine salt forcing strategies
Instead, we emphasize:
- Acid-stable vegetarian capsules designed to support structural integrity
- Structural peptide modifications such as acetylation and amidation where applicable
- Manufacturing processes focused on purity, consistency, and clarity
- Transparent formulation philosophy
Toxicological & Regulatory Context
SNAC (Salcaprozate Sodium) is a pharmaceutical permeation enhancer originally developed for oral drug delivery. Its mechanism involves membrane fluidization and localized pH modification.
Summary of Reported Biological Effects
| System | Reported Effect | Mechanism |
|---|---|---|
| Mitochondria | Inhibition of ATP synthesis | Interference with ETC complexes (see FDA review) |
| Metabolic | Lactic acidosis at high doses | Shift to anaerobic metabolism |
| Gastrointestinal | Mucosal irritation & barrier reduction | Membrane fluidization, local pH buffering |
| Reproductive | Fetotoxicity in animal models | Trans-placental exposure |
Aging is inevitable. How you age is a choice.
Beyond Standard Industry Capabilities
We produce unique acetylated and amidated peptide structures that reflect structural features studied in naturally occurring peptides and are not standard across all peptide production processes.
Peptide Terminal Modifications
N-terminal Acetylation
Acetylation involves the addition of an acetyl group (CH₃CO–) to the N-terminus, neutralizing the positive charge.
C-terminal Amidation
Amidation involves conversion of the C-terminal carboxyl group (COO⁻) to a neutral amide (CONH₂).
